Literature DB >> 9705838

Intracellular aggregate formation of dentatorubral-pallidoluysian atrophy (DRPLA) protein with the extended polyglutamine.

T Miyashita1, K Nagao, K Ohmi, H Yanagisawa, Y Okamura-Oho, M Yamada.   

Abstract

Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disorder caused by the abnormal CAG triplet-repeat expansion resulting in an elongated polyglutamine (polyQ) stretch. We have recently showed that the DRPLA protein is cleaved during apoptosis by caspase-3, one of the cysteine protease family members known to be activated during apoptosis. We report here the subcellular localization of the DRPLA protein by fusing the green fluorescent protein as a tag. The full length DRPLA protein is localized predominantly but not exclusively in the nucleus regardless of the length of the polyQ stretch. In contrast, an N-terminal-deleted fragment containing polyQ produced by the proteolytic cleavage with caspase-3 is found both in the nucleus and the cytoplasm. Moreover, the same fragment with the elongated polyQ showed aggregation when overexpressed. Some cells with aggregate formation showed apoptotic phenotype. These findings raise the possibility that the DRPLA protein processed by caspase-3 may lead to aggregation of the protein resulting in the development of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705838     DOI: 10.1006/bbrc.1998.9096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Frequent occurrence of protein isoforms with or without a single amino acid residue by subtle alternative splicing: the case of Gln in DRPLA affects subcellular localization of the products.

Authors:  Keiko Tadokoro; Mayu Yamazaki-Inoue; Maki Tachibana; Mina Fujishiro; Kazuaki Nagao; Masashi Toyoda; Miwako Ozaki; Masami Ono; Nobuhiro Miki; Toshiyuki Miyashita; Masao Yamada
Journal:  J Hum Genet       Date:  2005-08-10       Impact factor: 3.172

3.  Histone deacetylase inhibitors reduce polyglutamine toxicity.

Authors:  A McCampbell; A A Taye; L Whitty; E Penney; J S Steffan; K H Fischbeck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

4.  Polyglutamine expansion alters the dynamics and molecular architecture of aggregates in dentatorubropallidoluysian atrophy.

Authors:  Justyna Hinz; Lothar Lehnhardt; Silke Zakrzewski; Gong Zhang; Zoya Ignatova
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

5.  Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor.

Authors:  V Panet-Raymond; B Gottlieb; L K Beitel; H Schipper; M Timiansky; L Pinsky; M A Trifiro
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

Review 6.  Impairment of Lysosome Function and Autophagy in Rare Neurodegenerative Diseases.

Authors:  Frédéric Darios; Giovanni Stevanin
Journal:  J Mol Biol       Date:  2020-03-05       Impact factor: 5.469

Review 7.  Roles of Post-translational Modifications in Spinocerebellar Ataxias.

Authors:  Linlin Wan; Keqin Xu; Zhao Chen; Beisha Tang; Hong Jiang
Journal:  Front Cell Neurosci       Date:  2018-09-19       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.